These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3152634)

  • 1. Evaluation of class II major histocompatibility complex antigen expression for the differential diagnosis of cyclosporine A nephrotoxicity from kidney graft rejection.
    Barrett M; Milton AD; Barrett J; Taube D; Bewick M; Parsons VP; Fabre JW
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1769-71. PubMed ID: 3152634
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA-class II antigen induction does not exclude a diagnosis of cyclosporine nephrotoxicity.
    Fuggle SV; McWhinnie DL; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1525-6. PubMed ID: 2652491
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunohistological analysis of renal allograft biopsies from cyclosporin-treated patients. Induced HLA-class II antigen expression does not exclude a diagnosis of cyclosporin nephrotoxicity.
    Fuggle SV; McWhinnie DL; Morris PJ
    Transpl Int; 1989 Oct; 2(3):123-8. PubMed ID: 2679626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of class II antigen: marker for rejection?
    O'Brien J; Horsburgh T; Veitch PS
    Transplant Proc; 1987 Feb; 19(1 Pt 1):211-2. PubMed ID: 3152689
    [No Abstract]   [Full Text] [Related]  

  • 5. Early induction of MHC antigens in human liver grafts. An immunohistologic study.
    Gouw AS; Huitema S; Grond J; Slooff MJ; Klompmaker IJ; Gips CH; Poppema S
    Am J Pathol; 1988 Oct; 133(1):82-94. PubMed ID: 3052095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The differentiation of acute renal allograft rejection and cyclosporine nephrotoxicity by simple urine cytology.
    Williamson EP; Millar RJ; Criddle RA; Sells RA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1785-6. PubMed ID: 3274423
    [No Abstract]   [Full Text] [Related]  

  • 7. Donor pretreatment with IFN-gamma enhances MHC class II antigen expression and accelerates graft rejection by modified recipients.
    Ijzermans JN; Bouwman E; Jeekel J; Marquet RL
    Transplant Proc; 1990 Aug; 22(4):1941-2. PubMed ID: 2117821
    [No Abstract]   [Full Text] [Related]  

  • 8. [The diagnosis of cyclosporin nephrotoxicity in patients after kidney transplantation].
    Rozental' RL; Il'inskiĭ IM; Bitsans IaB; Strokan' VA
    Ter Arkh; 1990; 62(6):92-4. PubMed ID: 2218937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antilymphoblast globulin treatment of steroid-resistant rejection in cyclosporine-immunosuppressed renal transplant recipients.
    Tellis VA; Matas AJ; Quinn TA; Glicklich D; Weiss RJ; Soberman RJ; Veith FJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1892. PubMed ID: 3274447
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of antithymocyte globulin and cyclosporine to treat steroid-resistant rejection episodes in renal transplant recipients.
    Benvenisty AI; Tannenbaum GA; Cohen DJ; Appel G; Hardy MA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1889-91. PubMed ID: 3274446
    [No Abstract]   [Full Text] [Related]  

  • 11. Has cyclosporine really relegated pretransplant blood transfusions to therapeutic obsolescence?
    Melzer JS; Husing RM; Feduska NJ; Tomlanovich SJ; Vincenti F; Amend WJ; Garovoy M; Salvatierra O
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1971-3. PubMed ID: 2856274
    [No Abstract]   [Full Text] [Related]  

  • 12. Absence of class II major histocompatibility complex antigen induction in cyclosporine A--treated recipients of heart and kidney allografts in the rat.
    Milton AD; Spencer SC; Fabre JW
    Transplant Proc; 1987 Feb; 19(1 Pt 1):192-4. PubMed ID: 3152686
    [No Abstract]   [Full Text] [Related]  

  • 13. Sequential studies of major histocompatibility complex antigen expression (common class I and class II determinants, DR and DQ) in cardiac biopsies following human cardiac transplantation.
    Suitters A; Rose M; Khaghani A; Yacoub M
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2566-7. PubMed ID: 3274565
    [No Abstract]   [Full Text] [Related]  

  • 14. Local inhibition of major histocompatibility complex class II induction within the graft: an effective way to induce immunosuppression.
    Ruers TJ; Buurman WA; van der Linden CJ; Kootstra G
    Transplant Proc; 1987 Feb; 19(1 Pt 1):246-7. PubMed ID: 3152698
    [No Abstract]   [Full Text] [Related]  

  • 15. Differentiation of cyclosporine A-induced nephrotoxicity from acute rejection in renal transplantation using fine-needle aspiration biopsies.
    Zannier A; Mutin M; Touraine JL; Traeger J
    Transplant Proc; 1987 Oct; 19(5):3630-2. PubMed ID: 3313874
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular analysis of graft survival in renal transplantation by DNA typing of HLA class II antigens.
    Tsuji K; Inoko H; Ando A; Matsuno N; Ikewaki N; Sato T; Ichikawa Y; Sonoda T
    Transplant Proc; 1987 Feb; 19(1 Pt 1):662-3. PubMed ID: 3152706
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo immunosuppressive effect and the decreasing expression of MHC class II antigens by purine nucleoside phosphorylase inhibitor 8-amino-9-benzylguanine in recipient tissues of canine renal allograft rejection.
    Yen CY; Lin CY
    J Surg Res; 1996 May; 62(2):260-6. PubMed ID: 8632649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of rabbit globulin anti-CD4+ lymphocyte clone derived from a rejected kidney in the prevention of rejection in kidney transplantation: a pilot study.
    Hourmant M; Babinet F; Cantarovich D; Latour M; Carcagne J; Vié H; Bonneville M; Moreau JF; Carosella E; Soulillou JP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1587-8. PubMed ID: 2652516
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of the clinical, histopathologic, cytologic, and biochemical features of renal transplant rejection, cyclosporine A nephrotoxicity, and stable renal function.
    Taube D; Neild G; Hobby P; Holt D; Welsh K; Cameron JS
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):179-84. PubMed ID: 3895658
    [No Abstract]   [Full Text] [Related]  

  • 20. Definition, diagnosis, and management of rejection in the second to sixth months posttransplant--an overview.
    Matas AJ; Tellis VA; Quinn T; Soberman R; Veith FJ
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):141-50. PubMed ID: 3515682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.